Clinical Trial Update: TAP Block Using Liposomal Bupivacaine for Post-cesarean Delivery Analgesia- Walking Towards Recovery [Phase 4]

View source ↗

Summary

A Phase 4 trial sponsored by Yale University evaluating liposomal bupivacaine (Exparel) for post-cesarean analgesia was terminated, with results posted in March…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Pain

Drugs mentioned

• Exparel (liposomal bupivacaine) (liposomal bupivacaine)

Snippet

Sponsor: Yale University | Conditions: Opioid Use, Pain, Acute | Phase 4 | Status: TERMINATED | Results posted: 2025-03-21